COX-2 expression positively correlates with PD-L1 expression in human melanoma cells. - Wikidata - wikimedia - TriplyDB

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

http://www.wikidata.org/entity/Q37663388

about

Mechanisms and prevention of UV-induced melanoma.Intratumor and Intertumor Heterogeneity in Melanoma.Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma.Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.Ultraviolet radiation-induced immunosuppression and its relevance for skin carcinogenesis.Prostaglandin E2 Induction Suppresses the Th1 Immune Responses in Cattle with Johne's Disease.Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy.

P2860

Q39432336-1020CC36-D687-41E2-BEB7-09BBFB04D8E4 Q46742817-2D6FBF88-6ED6-462C-AE1F-9EFBDBB140F4 Q47152515-B9BFDACD-AC90-4401-B71C-0CA012EEFF3A Q47224948-CF4027E6-5E23-44DB-B83B-9572F4EE4922 Q47840579-AB627577-2677-4E52-9300-BD366604952C Q52684416-3A2B27C7-8442-441E-A6FF-38189BB3E1AB Q55398181-F9394BC8-E816-4DA8-87C2-9C2015DC069E

P2860

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

http://www.wikidata.org/entity/Q37663388

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

@en

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

@nl

type

label

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

@en

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

@nl

prefLabel

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

@en

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

@nl

P1433

Q37663388-1CD7E920-3AC3-4976-B14E-66BA3B3EFA92

P1476

Q37663388-880ED528-81C0-4EF0-9D98-A1B1FDD1B0A2

P2093

Q37663388-232E956E-030F-4452-86C2-9E52931353CF

Q37663388-28B4A7DA-716F-41F6-A1BF-7E1F80F98C5D

Q37663388-600C1B4F-5A5C-4F08-942F-CAE4D71BBAED

Q37663388-7871D630-D059-430F-AE07-C3A02799FC79

Q37663388-86106152-01D8-4A84-930E-57BC82295B96

Q37663388-8F352AD7-B15F-4126-B5A6-FC6FA9F125BC

Q37663388-AB0CB0FD-C05F-433E-8FA8-4BE26FF4E683

Q37663388-B3639DDE-A17E-435A-8335-BBF663DA83C3

P2860

Q37663388-016C73E3-0713-438E-9ADC-06E4BF51D05D

Q37663388-035423A4-2818-4B32-BAF5-0E866ABA419A

Q37663388-0845FA5A-C30B-4D40-9EEB-3A6861C23ECC

Q37663388-08C76992-A456-4C28-87C9-9A0D653A873E

Q37663388-0CAC1522-4D95-4616-AEA1-F95A962C7931

Q37663388-23166D2B-2B59-495C-B918-FB217A0351FE

Q37663388-2DB98320-4E6C-4698-A769-A14EDB55D93C

Q37663388-2F67EC13-456C-4A86-96FC-369DB690C4DB

Q37663388-31B77B31-B699-4197-90DE-4B33929B246F

Q37663388-35E97ECD-0C22-468F-A62A-FD2C9FD21E6A

P2888

Q37663388-27F0FF5E-3D7D-4697-BEDA-AEA0876DA727

P304

Q37663388-E415F7EF-B4BF-4B6E-84F5-CA076E7EEB2E

P31

Q37663388-8D8DDEB7-463C-41C9-92AE-DCBDD0622F32

P356

Q37663388-27E70D01-C3B4-48EB-9BE5-A7DD89CCFC56

P433

Q37663388-6C776763-DD09-4A7F-98E0-BC92FE6E2A90

P478

Q37663388-5BAE5A54-43DE-4243-96F9-2EF7B0FBA804

P50

Q37663388-01224332-D792-4306-878F-D827409483D2

Q37663388-4A24BBFC-9AF8-4B6C-A7F1-048D132A1315

Q37663388-53E62FA5-14CA-41A3-A837-674BFA4FE36F

Q37663388-74F855A9-053D-469B-911F-296E72B72887

Q37663388-7563C773-1856-4FB0-BC26-CE321B805516

Q37663388-7A827306-CC22-4496-989F-635FC9440540

Q37663388-8599159A-A68B-4E48-95A3-F668D5F3F43D

Q37663388-BFDB16C0-EF41-4931-B623-8D5EF0A9DD32

Q37663388-C4AF95B9-B6AE-4F09-B8AC-27A63352EE15

Q37663388-D8338494-F6DA-4E5D-A193-213F7C8AE00F

P577

Q37663388-D312E360-7466-4507-844C-BB42D89ABEC1

P6179

Q37663388-EF650EA4-07F1-4A59-A527-4953578AA989

P698

Q37663388-AFB9E561-7E75-4660-A251-57329FDADEEB

P932

Q37663388-29FED436-ADA0-4106-878E-DA7FB623D489

P356

S12967-017-1150-7

P1433

Journal of Translational Medicine

P1476

COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.

@en

P2093

Angela Ianaro

http://www.w3.org/2001/XMLSchema#string

Anna Maria Anniciello

http://www.w3.org/2001/XMLSchema#string

Chiara Trimarco

http://www.w3.org/2001/XMLSchema#string

Federica Fratangelo

http://www.w3.org/2001/XMLSchema#string

Francesco Sabbatino

http://www.w3.org/2001/XMLSchema#string

Giuseppe Cirino

http://www.w3.org/2001/XMLSchema#string

Maria Colombino

http://www.w3.org/2001/XMLSchema#string

Stefano Pepe

http://www.w3.org/2001/XMLSchema#string

P2860

Human cyclooxygenase-2 cDNA

Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations

Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity

Subverting the B7-H1/PD-1 pathway in advanced melanoma and kidney cancer

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.

Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis.

Nivolumab plus ipilimumab in advanced melanoma.

Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma

Mutations of the BRAF gene in human cancer

P2888

s12967-017-1150-7

P304

46

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-017-1150-7

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Palmieri

Paolo Antonio Ascierto

Giosuè Scognamiglio

Crescenzo D'Alterio

Corrado Caracò

Margherita Cerrone

Giuseppina Liguori

P577

2017-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083861556

http://www.w3.org/2001/XMLSchema#string

P698

28231855

http://www.w3.org/2001/XMLSchema#string

P932

5324267

http://www.w3.org/2001/XMLSchema#string